BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33661328)

  • 1. Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.
    Nawwar AA; Searle J; Singh R; Lyburn ID
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2657-2658. PubMed ID: 33661328
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma.
    Avner M; Orevi M; Caplan N; Popovtzer A; Lotem M; Cohen JE
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2659-2660. PubMed ID: 33675368
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
    McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
    AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT.
    Xu G; Lu Y
    Clin Nucl Med; 2021 Apr; 46(4):353-354. PubMed ID: 33591026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
    El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
    Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT.
    Surasi DSS; Lin L; Ravizzini G; Wong F
    Clin Nucl Med; 2022 Feb; 47(2):195-196. PubMed ID: 34507331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT.
    Nawwar AA; Searle J; Hagan I; Lyburn ID
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2655-2656. PubMed ID: 33638003
    [No Abstract]   [Full Text] [Related]  

  • 9. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.
    McIntosh LJ; Rosen MP; Mittal K; Whalen GF; Bathini VG; Ali T; Edmiston KL; Walsh WV; Gerber JM
    Cancer Treat Rev; 2021 Jul; 98():102220. PubMed ID: 34029956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
    Smith MV; Yang M
    J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
    Seban RD; Champion L; Yeh R; Schwartz LH; Dercle L
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3351-3352. PubMed ID: 34164727
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
    Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
    Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
    Weeks JK; O'Brien SR; Rosenspire KC; Dubroff JG; Pantel AR
    Clin Nucl Med; 2021 Dec; 46(12):1011-1012. PubMed ID: 34735411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [
    Cohen D; Hazut Krauthammer S; Wolf I; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1338-1344. PubMed ID: 34651230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.
    Bass D; Puri S
    AJR Am J Roentgenol; 2022 Jan; 218(1):180. PubMed ID: 34259040
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.
    Bshesh K; Khan W; Vattoth AL; Janjua E; Nauman A; Almasri M; Mohamed Ali A; Ramadorai V; Mushannen B; AlSubaie M; Mohammed I; Hammoud M; Paul P; Alkaabi H; Haji A; Laws S; Zakaria D
    J Med Virol; 2022 May; 94(5):1833-1845. PubMed ID: 35060149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on
    Chiang MT; Wang JT; Lin WY; Yen RF; Huang JY; Lu CC
    Eur J Med Res; 2023 Nov; 28(1):513. PubMed ID: 37964395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.
    Nawwar AA; Searle J; Lyburn ID
    Clin Nucl Med; 2022 Jan; 47(1):e89-e90. PubMed ID: 34269722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT.
    Sollini M; Gelardi F; Biroli M; Chiti A
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):791-795. PubMed ID: 34928399
    [No Abstract]   [Full Text] [Related]  

  • 20. [
    Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; GrĂ¼nig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
    Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.